Digital health company Happify has signed a partnership with another biopharma company, joining forces with Biogen on a toolkit to help people with multiple sclerosis manage their illness. The digital toolkit is designed to keep patients informed of new treatments,…
Rune Labs gets FDA clearance to use Apple Watch to track Parkinson’s symptoms
San Francisco-based startup Rune Labs on Monday said it received clearance from the U.S. Food and Drug Administration to use the Apple Watch to monitor tremors and other common symptoms in patients with Parkinson’s disease. The Rune Labs software uses…
Is Merck planning a $30bn-plus move for Seagen?
Speculation that Merck & Co may be preparing a $30 billion takeover bid for Seagen – bolstering its oncology ambitions – has the biopharma community aflutter. The rumour was first published in the Wall Street Journal, which suggests that a…
Alimetry nabs FDA okay for gastric disorder-diagnosing wearable
New Zealand medical tech startup Alimetry has claimed an FDA approval for a wearable device that can be used to diagnose gastric disorders non-invasively. The Gastric Alimetry device will be marketed and distributed in the US by a new Minneapolis-based…
Labcorp partners with HealthVerity to boost clinical trial programmes
Labcorp can utilise the HealthVerity IPGE platform to align de-identified patient data with greater accuracy. Labcorp has entered a new partnership with HealthVerity to bolster its end-to-end drug development and clinical trial programmes. HealthVerity is provider of identity, privacy, governance,…
uMotif, ClinOne collaborate to boost participant experience in trials
The companies’ platforms can enable DCTs, standard site-based trials and hybrid designs of any scale or treatment area complexity. uMotif has entered a collaboration with ClinOne to combine electronic clinical outcome assessments (eCOA) / patient reported outcomes (ePRO) and electronic…
Central Drugs Laboratory (CDL) in Kasauli Clears Pill-based Covid Vaccine for Phase 2 Clinical Trials in India
As India’s apex vaccine testing laboratory clears a batch of oral tablet-based Covid-19 vaccine, American biotechnology company, Vaxart, moves a step closer to begin its phase II clinical trial in India soon. India is a part of the company’s global…
Phase I Clinical Trial Centres to be developed: ICMR
With an aim to improve therapeutic regimens and ensure advancement in medical practice that is evidence based, the Indian Council of Medical Research (ICMR), the apex body in India for the formulation, coordination and promotion of biomedical research, is set…
Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants, says ICMR study
The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19’s Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found. The protective efficacy of Bharat Biotech’s Covaxin…
FDA’s treatment of China-developed drugs spurs demands for multiregional clinical trials
China’s emergence as an R&D powerhouse means that the country is quickly adding a number of drug candidates to the global pipeline. Despite more treatment options being a positive, Ben Hargreaves finds that this has raised issues over single-region clinical…
